Dismisses Data Centers

DigitalBridge CEO Dismisses Data Centers in Space

Brussels to Big Tech: Embrace sustainable AI or go away

BRUSSELS — The European Union’s energy chief says companies that want to profit off the artificial intelligence boom are welcome in Europe — but only if they demonstrate they are committed to the bloc’s energy, climate and environmental goals. That means supporting renewable and nuclear power sources rather than fossil fuels, and recycling the amounts of excess heat from data centers to heat Europeans’ homes and businesses, EU Energy Commissioner Dan Jørgensen told POLITICO in an...

AI Is Slowing Down

If you liked this piece, you should subscribe to my premium newsletter. It’s $70 a year, or $7 a month, and in return you get a weekly newsletter that’s usually anywhere from 5,000 to 18,000 words, including vast, detailed analyses of NVIDIA, Anthropic and OpenAI’s finances, and the AI bubble writ large (updated to version 3.0 last week). My Hater's Guides To the SaaSpocalypse, Private Credit and Private Equity are essential to understanding our current financial system, and my guide to how...

OpenAI Confidentially Files for IPO on the Heels of SpaceX and Anthropic

OpenAI has filed confidential paperwork for an initial public offering, the company announced on Monday, kicking off what could be a monthslong process toward debuting on a US stock exchange. The move makes it the third company to file for what could be a trillion-dollar IPO this year. Tech companies pursuing the most powerful AI models, including publicly traded giants Alphabet, Amazon, Meta, and Microsoft, are hungry for tens of billions dollars each to build out more data centers and...

After losing my daughter, I learned where the immigration crisis really begins

My youngest daughter Katie was killed when an intoxicated illegal immigrant slammed into the back of the vehicle she was riding in at nearly 80 miles an hour while it sat idle at a stoplight. Ever since, I have been trying to understand how reckless public policies allowed something so horrific, and so preventable, to happen. Katie’s death forced me to look beyond slogans and political talking points and ask harder questions about what America’s immigration system has become, who benefits...

Here are the 6 big things we're watching in the stock market this week

Earnings season for Club names has come to an end, but that doesn't mean the excitement has. This coming week is packed with market-moving inflation data and two key corporate events. Apple's Worldwide Developers Conference starts its five-day run on Monday, and Apple is expected to raise the curtain on a new, conversational Siri assistant, powered by Google's powerful Gemini artificial intelligence model.

Policy on the AI Exponential

Policy on the AI Exponential In one of the side plots to The Lord of the Rings, two of the Hobbits attempt to rouse Treebeard—a wise but ponderous sentient tree—to defend his forest from an army that is cutting it down. The problem is that Treebeard operates at a very different speed than the Hobbits. It takes him a full day simply to say hello to another tree, so getting him and his peers to act fast enough is nearly impossible.

Takeaways from Iowa's primaries. And, DOJ nixes Trump's 'anti-weaponization' fund

Takeaways from Iowa's primaries. And, DOJ nixes Trump's 'anti-weaponization' fund Primary Results, DOJ Scraps Anti-Weaponization Fund, Trump Appoints Acting DNI Good morning. You're reading the Up First newsletter.

ICE is now requiring additional training for agents hired under Trump’s push: report

ICE is now requiring additional training for agents hired under Trump’s push: report The fast-tracked ICE training program began as the Trump administration pushed to hire 10,000 new agents to expedite the deportation of tens of thousands of people — but officials have since scrapped the program - Bookmark - CommentsGo to comments Immigration and Customs Enforcement is now requiring additional training for agents hired under the Trump administration’s now-scrapped accelerated training...

Biotech takeover target Abivax sinks over 30% after bowel disease drug trial update

Shares of French biotech Abivax tumbled as much 32% after it reported fresh data on its lead asset, a drug for ulcerative colitis. The medicine met its endpoints of demonstrating a clinically meaningful efficacy and a remission rate of about 40% for both doses tested, but also showed that there were cancer cases among patients taking the higher dose. "[The] cancer signal complicates matters," a Jefferies analyst said.